Background: Urinary incontinence is a common chronic health problem among women. Because physical therapists are likely to see patients postoperatively, therapists may play a role in screening for postoperative complications. The purpose of this case report was to demonstrate the importance of carefully monitoring a woman's response to physical therapy (PT) intervention post-tension-free vaginal tape-obturator sling procedure whose persistent symptoms were due to sling failure. Study Design: This is a PT case report that examined patient outcomes and response to PT interventions to determine appropriate referral to a urogynecologist. Case Description: A 62-year-old female patient presented with recurrence of urinary urgency, frequency, and leakage 9 months status post-tension-free vaginal tape-obturator sling surgery. The patient was seen for 8 visits over a 12-week period. Interventions included biofeedback, pelvic fl oor exercises and home program, instruction in "the Knack," extracorporeal magnetic treatment, and bladder retraining. Outcomes: Although the patient's score on the Urogenital Dist ress Inventory Short Form 6 improved from 62.5 to 33.3, analysis of the individual questions demonstrated mixed improvement. The patient's Pelvic Floor Impact Questionnaire-Short Form 7 urine/bladder score worsened from 61.9 to 66.7. Bladder diary outcomes were mixed. She was referred to her urogynecologist because of mixed outcomes combined with failure to achieve all long-term goals within 8 treatment sessions. Subsequent urodynamic testing revealed sling failure. Discussion: This case report demonstrated the importance of carefully monitoring a woman's response to PT intervention post-tension-free vaginal tape-obturator sling procedure whose persistent symptoms were due to sling failure.
INTRODUCTION
Urinary incontinence (UI) is a common chronic health problem with a prevalence of 45% to 49.2% among women in the United States. 1, 2 More specifi cally, rates for stress urinary incontinence (SUI), urge urinary incontinence (UUI), and mixed urinary incontinence (MUI) are reported to be 23.7%, 9.9%, and 14.5%, respectively. 1, 2 Prevalence rates for overactive bladder (OAB), a condition that includes frequency, urgency, and UUI, either alone or in combination, range from 3% to 43%. 3 Urinary incontinence costs in the United States are approximately $16.3 billion per year (1995 dollars). [4] [5] [6] For the purposes of this case report, language consistent with the recommendations of the International Continence Society was used. 7 Surgery constitutes a common intervention for w omen with UI. The lifetime risk of undergoing surgery for prolapse or UI is 11.1%. 8 Approximately 4% of women will undergo SUI surgery during their lifetime. 9 Indeed, the rate at which women undergo surgery for UI nearly doubled from 1979 to 1997, from 0.32 procedures per 1000 women per year in 1979 to 0.60 procedures per 1000 women per year in 1997. 10 Each year, an average of 300 000 women require inpatient surgery for SUI or pelvic organ prolapse. This number may approach 400 000 if outpatient procedures are also included. 8, 10, 11 Notably, approximately 29% (116 000) of these surgeries are reoperations. 8, 11 In 2001, Delorme 12 developed the tension-free vaginal tape-obturator (TVT-O) technique. Because this technique is less invasive than other procedures (eg, Burch colposuspensions, pubovaginal slings), and tension-free vaginal tape (TVT) procedures, it should theoretically be associated with fewer intraoperative complications. [12] [13] [14] [15] [16] Whereas the TVT-O creates a hammock to support the urethra, the TVT techniques provides urethral suspension. 17 With the TVT-O method, a tension-free sling is passed through the obturator foramens and toward the thigh folds. It is then placed under the junction between mid-and distal urethra. 13, 18 Because the needle is passed through a vaginal incision and out through the obturator foramen, the pelvic region is completely avoided. 19 The mechanical interaction between the tape and urethra allows the TVT-O to achieve its effectiveness. 20 Numerous studies have found the TVT-O to be a simple, effective surgical treatment option for patients with SUI. 13, 17, 18, 21, 22 However, the TVT-O procedure can result in complications such as vaginal/urogenital tract erosion, pelvic abscess, recurrent urinary tract infection, voiding diffi culty, persistent groin pain, wound infection, and de novo urgency. 17, 18, [21] [22] [23] [24] [25] Specifi cally, de novo urgency rates after surgery were reported as 9.1% to 15.2%. 17, 18, [24] [25] [26] Another team of researchers found new onset of urgency symptoms to be 11%, but they found that an additional 5% of subjects had worsening of urgency symptoms. 22 Latthe et al 19 found that although voiding diffi culties and bladder injuries were lower with TVT-O versus TVT, the risk of vaginal erosions and groin discomfort was signifi cantly higher. Even among successful surgeries, the "completely dry rate" was found to vary from 36.1% to 45.2%. 27 TVT-O treatment failure rates varied in numerous studies as follows: 11% at 9 months; 8% to 20% at 1 year; 20.4% to 37% at 2 years; 10.8% to 20.8% after 3 years; and 18.7% after 7 years. 13, 14, 16, 18, 26, 28, 29 Because the main function of sling surgery is to treat SUI, physical therapists commonly examine patients after these procedures to treat their remaining symptoms, usually concerning UUI or OAB. Physical therapists may also be consulted in reference to de novo symptoms of SUI, urgency, frequency, and UUI. 30 In addition, Jarvis et al 30 demonstrated that perioperative physical therapy (PT) improved both physical outcomes and quality of life in female patients who had undergone surgery for UI or pelvic organ prolapse.
As physical therapists are likely to see patients postoperatively, they may play a role in screening for postoperative complications. The task of conducting appropriate medical screenings as outlined in the Guide to Physical Therapist Practice 31 may fl ag potential problems that necessitate referral to another medical provider. DuVall and Godges 32 carry this concept 1 step further, emphasizing that the medical scr eening process should continue throughout the patient's plan of care, with special focus on the patient's response to PT treatment. They propose that a patient's lack of response to PT intervention indicates the patient may have comorbid medical conditions. 32 Thus, functional screening, operationally defi ned in this case report to be the careful monitoring of a postsurgical patient's response to PT intervention, constitutes an important role for the physical therapist.
The importance of carefully monitoring a patient's response to PT treatment in the functional screening of a patient with TVT-O sling failure has not yet been explored. Thus, the purpose of this case report was to demonstrate the importance of carefully monitoring a woman's response to PT intervention post-TVT-O sling procedure whose persistent symptoms were due to TVT-O sling failure. This report describes the patient's functional screening and differential diagnosis within the framework of the 5 elements of patient/client management as defi ned by the Guide to Physical Therapist Practice. 31 
STUDY DESIGN
This is a PT case report that examined patient outcomes and response to PT interventions to determine appropriate referral to a urogynecologist.
CASE DESCRIPTION Examination

History and Systems Review
The patient was a 62-year-old woman who presented with recurrence of urinary urgency, frequency, and nocturia as well as urinary leakage with sneezing and coughing status post-TVT-O sling surgery. She reported that after sling surgery, she had complete resolution of symptoms for approximately 9 months. She experienced a severe episode of bronchitis and an episode of painful sexual intercourse about the time her symptoms (including urgency, frequency, and UI) returned to presurgical levels. The patient underwent a follow-up visit with her urogynecologist, including pelvic examination and urinalysis, 1 week before commencing PT. She was referred to PT after she had a diagnosis of OAB. As per our faci lity policy, case reports do not require approval by the institutional review board. Written informed consent was obtained from the patient for PT examination and intervention as well as dissemination via publication. The rights of the subject were protected.
Medical history was signifi cant for non-insulindependent diabetes mellitus, hypertension, hypothyroidism, endometriosis, migraine headaches, bladder infections, 2 vaginal deliveries with episiotomies, and lumbar degenerative disc and joint disease. Surgical history was signifi cant for TVT-O sling surgery, hysterectomy (uterus only) due to endometriosis and bleeding 27 years before the TVT-O sling surgery, and lumbar surgery followed by removal of the lumbar hardware 2 years later due to complaint of "rectal pressure." The patient also noted an unsuccessful trial with 2 pessaries for SUI 6 months before the sling surgery. The patient's medications included Estratest (esterifi ed estrogens and methyltestosterone), Topamax (topiramate), Mavik (trandolapril), Byetta (exenatide), Synthroid (levothyroxine sodium), and Cytomel (liothyronine sodium).
Initial examination by a urogynecologist included urodynamic testing, which revealed SUI due to urethral hypermobility and low-pressure urethra. She also had a diagnosis of irritative lower urinary tract symptoms including urgency, frequency, nocturia, and UUI that was attributed to OAB or from scarring from prior surgery associated with endometriosis. The examination also noted a degree of spasm in the pelvic fl oor and anal muscles, possibly due to the patient's efforts to control spilling from her bladder. Finally, imaging revealed a cystic ovarian mass. The patient subsequently underwent an exploratory laparotomy, enterolysis of adhesions, excision of peritoneal mass, bilateral salpingo-oophorectomy, and TVT-O sling. The patient's TVT-O sling procedure was performed as follows: (1) an incision was made in the midline of the anterior vagina; (2) puncture incisions were made across the medial thigh just lateral to the thigh crease; (3) using the TVT-O device, the sling was positioned beneath middle urethra with the arms extending bilaterally across the obturator foramina and then across the puncture incisions at medial thigh; (4) tension of the sling was adjusted and the plastic sheath covering the sling was removed; (5) the free ends of the sling were cut beneath the skin of the medial thigh; and (6) the incisions across the vagina and medial thigh were closed with sutures. The TVT-O technique has been described in detail elsewhere in the literature. 18 
Systems Review
For purposes of medical screening, the patient completed a syst ems review form. 33 Review of all systems revealed elevated cholesterol levels, hypothyroidism, and constipation. In addition, systems review confi rmed history of urinary frequency, urgency, and incontinence, as well as degenerative joint and disc disease of the lumbar spine.
The patient's chief complaint included urinary urgency ("key-in-door" syndrome) and increased daytime and nocturnal frequency associated with UUI or OAB, as well as urinary leakage associated with SUI. The patient, a hairstylist, stated that she drank less fl uid at work and worried about timing toileting between clients and when she traveled. She expressed concern about the need to always carry spare clothing. Her goals for PT included "to have no bladder problems and to go back to the way I was right after my surgery."
The patient reported being sexually active and exercising regularly. She stated that she enjoyed social activities such as movies, dining out, and listening to music. Regarding urinary symptoms, the patient reported a toileting frequency of 17 times daily and 3 to 4 times nightly. She stated she leaked small to occasionally moderate amounts of urine 2 to 3 times daily and 3 to 4 times per week at night. She was able to delay the urge to urinate approximately 5 minutes. Strength of urine stream per self-report was strong and subjective urinary volume was large. She did not feel as though she completely emptied her bladder with voiding and complained of an occasional postmicturition dribble. She reported she was unable to slow or stop her fl ow of urine when voiding (ie, functional stop test grade of 0). Specifi cally, she reported urinary leakage with coughing, sneezing, walking ("key-in-door"), changing positions (getting up quickly), lifting her grandchildren, with strong urges, with vigorous activity and exercise, and while sleeping. She reported changing her mini-pad twice daily. She drank eight to ten 8-oz glasses of fl uids per day, of which 2 to 3 were caffeinated. She reported increased urgency after drinking caffeinated beverages but stated that she "needed them to wake up in the morning."
Regarding bowel symptoms, the patient reported 5 bowel movements per week. She could delay the urge to move her bowels for 1 hour. She denied fecal leakage. She complained of constipation and occasional straining during bowel movements. She stated that diabetes made it diffi cult to add fi ber to her diet.
Tests and Measures
The clinical impression obtained from the history was that the patient had symptoms consistent with UUI or OAB and SUI. The patient verbally consented to an internal vaginal examination. On inspection, skin integrity was intact with no erythema noted at the vaginal opening. No episiotomy scars or hemorrhoids were visible. There was no visual lift of the patient's perineal body with pelvic fl oor muscle (PFM) contraction. 34 During PFM contraction, accessory muscle contraction of the gluteals and adductors was visible. Bulging of the perineal body was present with involuntary PFM contraction (ie, cough refl ex) and with "bearing down." The anal wink refl ex was present. No pain was elicited with external palpation of the symphysis pubis, perineal body, ischiocavernosus, superfi cial transverse perineal, or levator ani. Sensa tion of dermatomes S1 to S5 was intact. Tissue support testing, as described by Haylen et al 35 to test for pelvic organ prola pse, was negative.
Outcome Assessment Tools
Vaginal palpation is widely performed by physical therapists to assess whether a patient can contract her PFMs, although real-time ultrasound imaging and magnetic resonance imaging may be more suited to measure the lifting aspect of the PFMs. 36 Although Bo and Finckenhagen 37 found that vaginal palpation is not reproducible, sensitive, or valid to measure PFM strength for scientifi c purposes, other researchers 38, 39 found a digital test of PFM strength to be both a reliable and valid tool. The "PERFECT SCHEME," which assesses PFM power (strength), endurance, repetitions, and fast contractions, has been shown to be both reliable and valid. 40 Pelvic fl oor muscle strength, which is measured via subjective digital assessment, is based on a modifi ed Oxford grading scale where 0 ϭ no contraction, 1 ϭ fl icker, 2 ϭ weak, 3 ϭ moderate, 4 ϭ good, and 5 ϭ strong. The grade can be adjusted with a "ϩ" or "Ϫ" symbol as necessary. 40 Pelvic fl oor muscle function is displayed in Table 1 .
The patient completed the Urogenital Distress Inventory Short Form 6 (UDI-6 Short Form), the Pelvic Floor Impact Questionnaire-Short Form 7 (PFIQ-7), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) on her fi rst visit and at the time of discharge ( Table 2 ). The PFIQ-7 and the Pelvic Floor Distress Inventory, including the subscale UDI-6, are reliable and valid qualityof-life questionnaires for women with pelvic fl oor disorders. 41 The PFIQ-7, which is used to determine how bladder symptoms affect relationships, activities, and feelings, includes 3 scales that are scored from 0 (least impact) to 100 (greatest adverse impact) and an overall summary score (0-300). 42 Items for the UDI-6 are assigned values of 0 for "not at all," 1 for "slightly," 2 for "moderately," and 3 for "greatly." 41 The average is then multiplied by 3 √33 to place the scores on a scale of 0 to 100, providing a single number that indicates overall symptoms distress. 41 Likewise, the PSIQ-12 is a reliable and valid method of evaluating sexual function in women with UI and/or pelvic organ prolapse. 43 PSIQ-12 scores are calculated by totaling the scores for each question, with 0 ϭ never, 1 ϭ seldom, 2 ϭ sometimes, 3 ϭ usually, and 4 ϭ always. Scores range from 0 to 48, where lower scores indicate better functioning.
The patient completed a 3-day bladder diary before the PT examination at the time of reevaluations and at discharge ( Table 3) . A bladder diary ha s been found to be a reliable method for determining frequency of urinary voiding as well as frequency of episodes of involuntary urinary leakage. 44
Evaluation/Diagnosis
The patient presented with decreased PFM strength and endurance. In addition, she presented with urinary urgency and frequency as well as urinary leakage with activities such as putting her key in her front door and while sleeping, which were consistent with her medical diagnosis of OAB. However, she also presented with complaint of loss of urine with coughing, sneezing, and jumping, which are more commonly associated with a medical diagnosis of SUI. This latter complaint was particularly alarming, as the patient was status post-TVT-O sling surgery with full relief of all symptoms until 9 months postsurgery. The working hypothesis was that the patient had impaired soft-tissue integrity as a result of TVT-O sling failure. The therapist suspected that 4 weeks of frequent coughing due to bronchitis 9 months after TVT-O sling surgery might have weakened and eventually compromised her soft-tissue integrity. The therapist thought it possible that the patient's episode of "brief stabbing pain" during intercourse may have actually been directly related to sling failure and thus the reoccurrence of her urinary symptoms.
The PT diagnosis for this patient as per the Guide to Physical Therapy Practice 31 was "4C Impaired Muscle Performance" due to weakness and dysfunction of her pelvic fl oor musculature. According to the International Classifi cation of Functioning, Disability Abbreviations: PFIQ-7, Pelvic Floor Impact Questionnaire-Short Form 7; PISQ-12, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire; UDI-6, Urogenital Distress Inventory Short Form 6. a Items for the UDI-6 are assigned values of 0 for "not at all," 1 for "slightly," 2 for "moderately," and 3 for "greatly." The average is then multiplied by 3 Ί33 to place the scores on a scale of 0 to 100, providing a single number that indicates overall symptoms distress. The PFIQ-7 includes 3 scales that are scored from 0 (least impact) to 100 (greatest adverse impact) and an overall summary score ( 35 ; that is, she had reduced strength and endurance due to the underlying pathophysiology. The patient's leakage resulted in activity limitations and restricted her participation in work.
Prognosis
Several systematic reviews of the literature demonstrated a common treatment length for PT treatment programs to be 8 to 12 weeks for UUI and MUI 45 and 6 to 12 weeks for SUI. [45] [46] [47] Given that the patient had signs and symptoms consistent with MUI, the therapist decided that the patient should attend PT sessions once weekly for 8 sessions.
Behavioral interventions such as bladder training are highly effective for reducing UI and OAB. 48 A retrospective study by Dorey et al 49 demonstrated tha t 85% of women with UUI who underwent a program of pelvic fl oor exercises and instruction in urge control techniques and fl uid management improved enough to avoid further intervention. Another study, which entailed a PT program of PFMs exercises and dietary recommendations, showed a 100% reduction in incontinence with vigorous exercise, urgency triggers, and sneezing and coughing after 6 weeks of intervention. 50 The therapist felt that the patient's prognosis regarding her urge symptoms was good. [48] [49] [50] An observational clinical study of PT management of women with SUI who received 4 to 6 visits demonstrated that 84% of the women were cured and 9% improved on stress testing and that signifi cant improvement was noted in all quality-of-life domains. 51 Given the hypothesis that the patient had impaired soft-tissue integrity and possible TVT-O sling failure, the therapist felt the patient's prognosis regarding SUI symptoms was guarded.
Because the patient may have had impaired softtissue integrity due to TVT-O sling failure, the therapist decided that if the patient did not achieve all of her long-term goals within 8 treatment sessions, she would be referred to her urogynecologist. The therapist did not feel that immediate referral back to the urogynecologist was warranted, as the patient had met with her physician 1 week before initiating PT. A formal reevaluation would be completed every 4 weeks to closely monitor the patient's progress toward goals and to ensure ongoing communication with her physician. The physical therapist and patient agreed upon the goals listed in Table 4 .
Intervention
At the fi rst visit, following examination, the patient received education regarding pelvic fl oor anatomy, normal bladder health, fl uid management, and dietary irritants to address her symptoms of urgency and frequency (Table 5 ). Diokno et al 52 showed in a randomized controlled trial that education on the aforementioned topics as part of a behavior modifi cation program improved continence status in women older than 55 years up to 1 year after treatment. Several studies have shown that reducing fl uid intake decreases urinary urgency, frequency, and urinary leakage. 53, 54 In the study by Hashim and Abrams, 53 a decreased daily fl uid intake of 25% was found to improve these symptoms. Alternately, Tomlinson et al 55 demonstrated that an increase in fl uid intake related to an increase in the amount of urine voided. The patient in this report was advised that decreasing fl uid intake could improve her symptoms. [53] [54] [55] It was recommended that she stop drinking fl uids 2 to 3 hours prior to bedtime. In addition, she was advised to perform vigorous ankle pumps with her legs elevated higher than her heart for a few minutes several hours before bedtime to decrease nocturnal frequency. 55 The patient reported she drank 16 to 24 oz of caffeinated fl uids per day. The relationship between caffeine intake and bladder symptoms is not clearly defi ned in the literature. Creighton and Stanton 56 found that detrusor pressure on bladder fi lling increased signifi cantly following oral caffeine consumption. Likewise, Arya et al 57 found an association between high caffeine intake and detrusor instability. Tomlinson et al 55 found that the relationship between decreased caffeine consumption and fewer episodes of daytime urinary leakage approached statistical signifi cance. However, Swithinbank et al 54 studied 69 women with either genuine SUI or idiopathic detrusor overactivity and found that changing from caffeinated to decaffeinated fl uids produced no improvement in patients' reported symptoms. The patient in this case report was advised to reduce her caffeine intake if possible to ascertain whether it improved her symptoms. The patient was also instructed that there might be a relationship between alcohol consumption and UI. 58, 59 On her second visit, the patient was educated regarding the association between bowel and urinary symptoms. The patient reported she had a diffi cult time eating enough fi ber due to a strict low-carbohydrate diet. I n a population-based crosssectional survey, Nuotio et al 60 found that constipation was a main health problem signifi cantly associated with voiding symptoms. Likewise, Pearson and Larson 61 identifi ed constipation as a risk factor for UI. Similarly, Byles et al 62 suggested that the strong association between constipation and UI may provide an opportunity to prevent UI among older women.
Thus, the patient was educated in toileting habits to lessen her UI risk profi le. Toileting strategies included attempting to defecate after a meal to coordinate with normal gastric refl ex; proper positioning, including sitting tall, leaning forward, and placing feet on stool to improve the anorectal angle for evacuation; and to avoid straining during bowel movements to prevent unnecessary stress on the pelvic fl oor musculature. 63 During sessions 2 to 8, the patient received biofeedback-assisted PFM training using SRS "ControlWorks" software from SRS Medical (Redmond, Washington). Although electromyography (EMG) is correlated with vaginal palpation of pelvic fl oor strength, it cannot be used to validate muscle strength measured by digital palpation. 37, 64 However, a study by Glazer et al 64 showed that intravaginal surface EMG is reliable and consistently predictive of important clinical variables, such as UI, SUI, UUI, and urinary urgency.
The effi cacy of biofeedb ack-assisted PFM exercises versus PFM exercises alone has been debated in the literature. A Cochrane review of the literature concluded that biofeedback-assisted PFM training is not superior to PFM exercises alone to reduce urinary symptoms. 45 In a critical review of prospective, randomized studies comparing biofeedback with unassisted PFMs exercise, Glazer and Laine 65 found that 9 studies showed that the biofeedback groups demonstrated statistically signifi cant improved outcomes whereas the other 9 studies showed no statistically signifi cant difference in improvement. 65 Morkved et al 66 found a high cure rate in both women training with and women training without biofeedback but proposed that using biofeedback in clinical practice may be helpful because it could motivate many
Short-term Goals
Status at Discharge Long-term Goals Status at Discharge
The patient will perform pelvic fl oor contractions without the use of accessory muscles to increase strength and improve socialization.
Met
Delay urinary urgency to 15 min to improve toileting function and to improve socialization. Met
The patient will decrease daily toileting frequency to 10-12 times to improve socialization and daily activities.
The patient will decrease daily toileting frequency to 8-9 times to improve socialization and daily activities.
Met (but not met at follow-up 2 mo after D/C)
The patient will decrease nighttime toileting frequency to 2 times to help facilitate a good night's sleep.
The patient will decrease nighttime toileting frequency to 1 time to help facilitate a good night's sleep. Met
The patient will decrease fl uid intake of coffee by 8 oz to help improve bladder function. Met
The patient will demonstrate independence in a pelvic fl oor home exercise program to help improve bladder function.
The patient will perform urge control techniques with supervision to help decrease leakage and improve socialization.
The patient will be independent with urge control techniques to help improve ability to work and socialization.
The patient will decrease urinary leakage to 3 times per week to facilitate ability to work. Not met The patient will decrease urinary leakage to once per week to facilitate ability to work and exercise. Not met Abbreviation: D/C, discontinued. women. 66 Biofeedback-assisted PFM training was used with this patient to address her weak and poor PFM coordination. Additional rationale for using biofeedback-assisted PFM training included working to increase EMG scores and contraction pressures of the PFM to improve quick contractions for SUI symptoms. 67, 68 Electromyography was initially used to train the PFM and was continued because of patient preference. The patient reported increased motivation to participate and confi dence in performing the home exercise program with the use of EMG. Therefore, biofeedback examination protocols and training exercises were completed during each training session for a total of 15 to 25 minutes ( Table 6 ). The patient chose to use perianal surface electrodes rather than a vaginal electrode.
Pelvic fl oor muscle training played an important role in the patient's treatment plan. Pelvic fl oor muscle exercise both alone and in combination with adjunctive modalities is an effective modality for treating UI. 45, 46, [69] [70] [71] [72] A recent Cochrane systematic review supported PFM training for the treatment of women with SUI, UUI, or MUI. 73 Choi et al 74 performed a meta-analysis of PFM training and concluded that training must include at least 24 contractions daily. The patient performed pelvic fl oor exercises in hook-lying, sitting, and standing and was educated in a comprehensive written home exercise program ( Table 7) .
The patient performed transverses abdominis (TrA) muscle con tractions, progressing from 5 repetitions with 5-second holds in sitting (session 3)
Treatment Interventions Session 1 Session 2 Session 3 Session 4 Session 5 Session 6 Session 7 Session 8
Education in pelvic fl oor anatomy X Table 6 In hooklying In sitting In sitting In sitting and standing
In sitting and standing
In sitting and standing
In sitting and standing Pelvic fl oor exercises and home exercise program: See Table 4 In to 10 repetitions with 10-second holds in standing (session 4). There is evidence that a co-contraction of the PFM with TrA contraction can be lost or altered in women with UI. 75 Given the patient's history of possible impaired soft-tissue integrity as a result of TVT-O sling failure, persistent symptoms of SUI, abdominal weakness, and l ow back pain status postsurgery and subsequent removal of hardware, she was educated in contracting her PFM along with low abdominal hallowing to facilitate TrA contractions. 76, 77 The patient was instructed on how to perform "the Knack" during sessions 3, 4 and 7 to address her leakage with coughing and sneezing. Miller et al 78 demonstrated that a well-timed PFM contraction before coughing can signifi cantly reduce urine loss in women with mild to moderate SUI. "the Knack" has been shown to contribute to success rates of women who participate in PT for UI. 79 During sessions 2 to 8, the patient underwent extracorporeal magnetic (EM) treatment for UI via the Neotonus chair. 80 The effi cacy of EM stimulation, which has been developed as an alternative to more invasive treatments such as electrical stimulation, has not been well established in the literature. [81] [82] [83] Numerous researchers have found that EM treatment has a benefi cial effect on women with SUI and OAB. [84] [85] [86] [87] [88] However, others have noted that the effects may be temporary, diminishing after 1 year. [89] [90] [91] [92] [93] Extracorporeal magnetic treatment has been shown to signifi cantly increase maximal intraurethral pressure during stimulation and maximal urethral closing pressure after stimulation, indicating that it could be helpful in the treatment of SUI. 94 Because the patient's initial PFM strength was 2-/5 and her PFM endurance and coordination were poor, rationale for EM stimulation included utilizing it as an aide to assist the patient in performing endurance contractions and quick contractions to improve PFM strength and endurance. We theorized that benefi cial effects from EM treatment could be maintained with a PFM home exercise program. Further rationale for the use of EM treatment included trying to increase the patient's urethral closing pressure in an effort to improve her symptoms related to SUI and to reduce the number of daily urge episodes to address the patient's complaint of urinary urgency. During a typical EM treatment session, a patient sits passively in the Neotonus chair and receives 10 minutes of EM stimulation targeting the slow-twitch PFM fi bers, followed by 10 minutes of EM stimulation targeting the fast-twitch PFM fi bers. However, to ensure maximal effi ciency and effectiveness, therapists at our facility commonly instruct patients to actively perform PFM exercises along with the EM unit. Thus, the patient in this case report received 10 minutes of EM treatment during which she performed active endurance exercises (holding for 8 seconds during the "active EM stimulation phase" and relaxing for 8 seconds during the "rest" phase), followed by a 2-minute rest period. She then received 10 minutes of EM stimulation during which she performed quick contractions (holding for 2 seconds for 3 repetitions during the "active EM stimulation phase" and then relaxing for 8 seconds during the "rest" phase). Intensity varied each time between 46% and 67% (where 100% intensity is the maximal EM output) on the basis of patient tolerance.
To address the patient's complaints of urinary urgency and frequency, the patient's treatment program included bladder retraining in the form of education in urge control techniques and timed voiding. Behavioral interventions, including bladder retraining, may be effective in improving UI. 44, 48, [95] [96] [97] [98] [99] [100] A randomized clinical trial by Fantyl et al 101 found that bladder training decreased the number of urinary leakage episodes by 57%, with a 54% reduction in quantity of fl uid loss. The patient in this case report was instructed in urge control strategies, including urge suppression through relaxation and distraction techniques. 44, 100 The initial bladder schedule included voiding every 1.5 hours during waking hours. This was increased weekly by 15-minute intervals, with an ultimate goal of voiding every 3 to 4 hours.
Outcomes
Outcomes for the UDI-6, PFIQ-7, and PISQ-12 detailed were mixed ( Table 2 ). The patient's UDI-6 and PISQ-12 scores improved from initial evaluation to discharge, but the PFIQ-7 scale scores worsened.
Although the patient's scale score on the UDI-6 improved, analysis of the individual questions demonstrated mixed improvement. The scores related to UUI or OAB symptoms improved, but the scores related to SUI symptoms worsened.
Scores on the PFIQ-7 worsened. At the time of discharge, the patient's ability to perform physical activities, to travel by car more than 30 minutes from home, and to participate in social activities outside of home were "moderately affected." Her emotional health was affected "quite a bit," and she was "quite a bit" frustrated.
The patient's PISQ-12 score improved over the course of treatment. The patient's report of incontinence with intercourse improved from "seldom" to "never," and fear of incontinence no longer restricted her sexual activity.
Bladder diary outcomes (Table 3) were mixed. After 4 weeks of treatment, she stated that she no longer had strong urgency, noting that she could enter her house without "running for the bathroom." The patient attributed the increased leakage from session 4 to session 7 to an increased number of "large sneezes," stating that she was better able to use "the Knack" with small sneezes. She also reported going on a boating trip, in which the boat rocked in rough seas, causing her to jump and subsequently lose urine. When questioned at the discharge interview regarding increased toileting frequency, the patient reported that she had consciously started going to the bathroom more often in an effort to decrease the amount of leakage with sneezing. The patient completed her fi nal bladder diary 1 month after learning from her physician that her sling had failed. She reported feeling frustrated and depressed and was concerned how undergoing a second surgery would impact her ability to work. She reported that she was trying to utilize the urge control techniques and "the Knack" when she remembered. However, after learning of the sling failure, she had discontinued her home exercise program and was instead waiting for the repeat sling surgery.
Vaginal palpation outcomes improved from session 1 to session 7 ( Table 1) . Although PFM strength improved, the patient's PFM strength was still quite weak (3-/5).
The outcome status of the patient's short-term and long-term goals at the t ime of her discharge from PT is presented in Table 4 . She was referred to her urogynecologist because of her mixed outcomes as described earlier combined with her failure to achieve long-term goal number 6 within 8 treatment sessions. Further urodynamic testing confi rmed the initial hypothesis of TVT-O sling failure.
DISCUSSION
The patient was referred to PT after she had a diagnosis of OAB and was found to have symptoms consistent with SUI and UUI or OAB. She received PT interventions including education in diagnosis, pelvic fl oor anatomy, normal bladder health, dietary irritants, fl uid management, constipation, and proper toileting; biofeedback-assisted PFM exercises; PFM exercises including education in a home exercise program; instruction in transverse abdominis contractions and "the Knack"; bladder retraining; and EM treatment. She was referred to her urogynecologist for further evaluation because of her mixed outcomes on the UDI-6, PFIQ-7, PISQ-12, and bladder diary coupled with her failure to achieve all long-term goals within 8 treatment sessions. The therapist realized that the patient's reoccurrence of SUI symptoms could have been due to sling failure but that numerous other conditions may also mimic genuine SUI, such as urinary tract infection, urinary retention/overfl ow incontinence, fi stula, urethral instability, diverticulum, and urethral syndrome. 102 Four weeks after her fi nal PT session, urodynamic testing confi rmed TVT-O sling failure. Anti-incontinence surgical failure can be defi ned as persistent SUI; de novo or urge incontinence; urinary retention; postoperative pelvic prolapse; irritating or obstructive voiding symptoms; or surgical complications such as dyspareunia, bleeding, infection, or fi stula. 103 TVT-O treatment failure rates varied in numerous studies as follows: 11% at 9 months; 8% to 20% at 1 year; 20.4% to 37% at 2 years; 10.8% to 20.8% after 3 years; and 18.7% after 7 years. 13, 14, 16, 18, 26, 28, 29 One study found only an 8.2% failure rate after 3 years but acknowledged the failure rate might have been higher if the 11% dropout rate was taken into account. 22 Numerous risk factors have been identifi ed for sling failure. One research study 9 found that the risk of sling failure was greater in women who underwent simultaneous TVT-O and pelvic organ prolapse surgery, in women who used anticholinergic medications before surgery, and in women of increasing age. Others 16, 104 found that the TVT-O failure rate increased in women who had undergone previous incontinence surgery and in women of increasing age (60 years or older). Two recent studies 105, 106 reported that previous incontinence surgery, a low mean urethral closure pressure at urodynamics, and detrusor overactivity were risk factors for transobturator midurethral sling failure, whereas another study 107 found signifi cant risk factors to be diabetes mellitus, mixed incontinence, intrinsic sphincter defi ciency, and body mass index greater than 25. A study by Richter et al 108 concluded that risk factors for stress failure 2 years after surgery include increased UUI symptoms over baseline, more advanced prolapse, and being menopausal without undergoing hormone replacement therapy.
The authors believe that the patient in this case report w as at increased risk for TVT-O sling failure. Her age of 62 years constituted a known risk factor for sling failure. 9, 16 In addition, the risk of sling failure increases in women who undergo simultaneous TVT-O and pelvic organ prolapse surgery. 22 Although the patient did not receive pelvic organ prolapse surgery, she did undergo simultaneous exploratory laparotomy, enterolysis of adhesions secondary to endometriosis, excision of peritoneal mass, and bilateral salpingo-oophorectomy. Thus, although the patient did not have prolapse surgery coincident with the TVT-O sling procedure, she did have multiple other pelvic procedures that would likely create similar trauma to the pelvic region. Furthermore, the patient was found to have low mean urethral closure pressure during initial urodynamic testing, which is a risk factor for sling failure. 105, 106 At the time of her initial consultation with her urogynecologist, the patient had a diagnosis of a possible OAB, which comprises yet another risk factor for TVT-O sling failure. 105, 106, 109, 110 Her complaint of increased UUI symptoms over her baseline further predisposed her to surgical failure. 107 Finally, the patient presented with MUI and reported a long-standing history of diabetes, both of which pose additional risk factors for sling failure. 107 The patient's history of non-insulin-dependent type II diabetes might have played a role in her development of UI, despite the fact that her blood glucose levels were well controlled. Patients with diabetes have a 30% to 70% increased risk of lower urinary tract symptoms, most often in the form of OAB and UUI. 110, 111 One theory is that diabetes may paralyze the detrusor, thus causing voiding dysfunction. 112 Per haps, future research could explore the mechanism whereby diabetes mellitus increases the risk of sling failure.
Several authors 9, 110, 113 have noted that low back pain is a risk factor for developing UI. In addition, patients with diabetes who undergo lumbar instrumentation with fusion have a signifi cantly increased risk of developing perioperative complications. 114 It is interesting to note that the patient underwent lumbar instrumentation with fusion in 1995 due to disc and joint disease. She reported that, almost immediately, she experienced pain from the screws and felt as though the weight of the hardware was pushing on her rectum. For this reason, she underwent surgery in 1997 to remove the hardware. The effect, if any, of the patient's history of multiple lumbar surgeries on the development of her UI and OAB or as a risk factor for sling failure remains unknown.
The initial working hypothesis was that the patient had impaired soft-tissue integrity as a result of TVT-O sling failure. Recurrent SUI, 115 complaint of UUI, 116 and dyspareunia 117 following TVT placement may signal urethral mesh/graft erosion. A case was reported in the medical literature regarding a female patient who sneezed on postoperative day 2 following transobturator sling surgery felt an immediate sharp pulling in her right groin and subsequently complained of recurrent SUI. 118 The patient was found to have a vaginal erosion and required repeat TVT-O surgery. 118 The patient in this case report complained of a 4-week long episode of severe bronchitis and an episode of dyspareunia. The therapist further hypothesized that the patient's chronic coughing gradually eroded the graft and that the patient's report of brief stabbing pain during intercourse signaled mesh failure.
Numerous authors [119] [120] [121] [122] have postulated that since UI is rarely life-threatening, PT can be initiated on the basis of patient history and clinical examination. However, failure of conservative treatment, such as PT, should call for a precise determination of the pathophysiology and etiology of the UI. 119 viewpoint melds with the approach detailed in the Guide to Physical Therapist Practice. 31 In this patient's case, she was given a trial of 8 sessions of PT. Throughout the sessions, the therapist questioned the patient about blood glucose levels to ensure that the patient's diabetes was not a contributing factor to her mixed outcomes. The therapist provided ongoing emotional support and encouragement to the patient in an effort to help her work through her frustration. Exercises were progressed each session in an effort to improve the patient's PFM function. The patient's UUI or OAB symptoms and urinary leakage while putting her key in the door and while sleeping resolved within 8 treatment sessions, which is consistent with outcomes in other research studies. 48, 49, 82 However, it is interesting to note that 2 months after discharge, although the patient's de novo urge symptoms were resolved, her urinary frequency increased. The therapist hypothesized that this may have been due to the patient's self-report of frustration and depression as a result of ongoing bladder symptoms in conjunction with confi rmation of her sling failure, the patient's reported decision to intentionally increase urinary frequency in an effort to decrease amount of leakage with sneezing, and noncompliance with her home exercise program after learning of the sling failure.
In contrast with other research studies 47,50,51 that showed resolution of SUI symptoms within 4 to 6 PT treatment sessions, the patient in this case report continued to leak with sneezing despite PT intervention. Also of note is the patient's limited improvement in PFM function, which may have contributed to her ongoing SUI. The therapist hypothesized that this limited improvement may have been at least partly due to questionable compliance with the patient's home exercise program due to her busy work schedule and social life. After session 7, the therapist contacted the physician's offi ce and discussed the possibility of sling failure with the physician's assistant. The patient was referred to her urogynecologist because of mixed outcomes combined with her failure to achieve all goals within 8 treatment sessions.
This case report has several limitations. Use of perianal electrodes may have adversely affected the accuracy of EMG recordings. Because of constraints inherent in the nature of a case report, causal relationships cannot be inferred between variables. In addition, results from a single case may not necessarily be generalized to a larger population. The design of a case report also precludes having a control. To improve functional screening and appropriate referral of patients with possible genitourinary pathology, randomized controlled trials should be performed among women receiving PT both before and after urogynecologic procedures.
CONCLUSION
This case report demonstrated the importance of carefully monitoring a woman's response to PT intervention post-TVT-O sling procedure whose persistent symptoms were due to sling failure.
